Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would take into consideration new talks with insurers regarding the listing price ranges of Wegovy and copyright if they pledge to help keep the medicines on their https://charlieypfvl.iyublog.com/30101741/how-much-you-need-to-expect-you-ll-pay-for-a-good-healthcare-news